888-536-7697 ext. 3103
oncologysupply.com
☰
˟
LOGIN FAILED - Invalid User Name / Password. Please Try Again
You have been logged out. Thank you
This is a warning feedback message
Pricing Alert

Precision Medicine Center

 The Precision Medicine Center is now available for all ION members. Log in today to access all of the resources and recommendations.
Pricing Alert

Genetic & Genomic Evolution

 In the fourth post of our series, learn about how genetic and gemonic testing has evolved throughout the years.
Pricing Alert

Review 2017 MIPS Feedback

 CMS has made a correction to the rates originally reported on the QPP website which could affect your 2019 MIPS payment adjustment.
Pricing Alert

Smart Rx Processing

 Learn how Smart Rx Processing reduces the administrative burden of in-office dispensing, enabling your staff to focus on the patient.
Pricing Alert

Lower Drug Prices

 Barry Fortner, PhD, recently commented on over 150 concepts laid out by the HHS Blueprint for Lowering Drug Pricing. Read his letter here.
Pricing Alert

Physician Compare

 CMS is adding star ratings to the Physician Compare website in 2018. Learn how to manage your practice’s reputation to keep, and attract new, patients.
Pricing Alert

New AMA President

 Congratulations to Barbara McAneny, MD, CEO of New Mexico Cancer Center, who was recently inaugurated as president of the American Medical Association.
Pricing Alert

Data's Effect on Reputation

 2016 scores are available in the Physician Compare Database. Learn what this data means for your practice.
Pricing Alert

Changes from 2017-2018

 Our Quality Reporting Engagement Group reported the top 10 differences in MIPS reporting from 2017 to 2018. Learn more.
Pricing Alert

MIPS Topped-Out Measures

 Understand and address "topped-out measures" as your practice conducts its 2018 MIPS reporting.
Pricing Alert

Top Trends in Cancer Care

 Barry Fortner, PhD, discusses the top trends influencing the future of affordable cancer care and how community oncology practices can adapt.
Breaking News
Have you asked your patients what they would prefer?
Learn about CALQUENCE dosing
Learn about NERLYNX® (neratinib) tablets in early-stage HER2+, HR+ breast cancer
Discover the PARPi approved for use in more patients with recurrent OC
View More
Videos
The Provider Perspective
Video 1 of 6
The Provider Perspective
AMERISOURCEBERGEN RESOURCES
Community Counts
Advocacy and legislative support
 IntrinsiQ Specialty Solutions
Analytics, technology, and consulting
 US Bioservices
Specialty pharmacy solutions
 OncologySupply
Chemo and supportive care orders